JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

JNJ

167.29

-0.43%↓

NVS

116.69

-0.32%↓

ABT

128.65

+0.56%↑

TMO

477.27

-1.09%↓

ISRG

500.18

+0.72%↑

Search

Smith & Nephew PLC ADR

Fermé

30.93 -2.06

Résumé

Variation du prix de l'action

24h

Actuel

Min

30.8

Max

31.59

Chiffres clés

By Trading Economics

Revenu

196M

Ventes

3B

P/E

Moyenne du Secteur

33.17

40.048

Rendement du dividende

2.41

Marge bénéficiaire

6.571

Employés

17,349

EBITDA

717M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

-7.41% downside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.41%

2.45%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

14B

Ouverture précédente

32.99

Clôture précédente

30.93

Score Technique

By Trading Central

Confiance

Bullish Evidence

Smith & Nephew PLC ADR Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 juil. 2025, 23:47 UTC

Résultats

Samsung Semiconductor Earnings Fell for Fourth Straight Quarter

30 juil. 2025, 23:45 UTC

Résultats

Samsung: Smartphone Business Oper Pft KRW3.1T in 2Q Vs KRW4.3T in 1Q

30 juil. 2025, 23:45 UTC

Résultats

Samsung: Semiconductor Business Oper Pft KRW0.4T in 2Q Vs KRW1.1T in 1Q

30 juil. 2025, 23:44 UTC

Résultats

Samsung Electronics 2Q Net Profit Missed FactSet-Compiled Consensus

30 juil. 2025, 23:43 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

30 juil. 2025, 23:38 UTC

Résultats

Samsung Electronics Co. Ltd. 2Q Consolidated Net KRW5.116T Vs KRW9.841T

30 juil. 2025, 23:38 UTC

Résultats

Table: Samsung Electronics 2Q Consolidated Net KRW5.116T Vs KRW9.841T

30 juil. 2025, 23:38 UTC

Résultats

Samsung Electronics Co. Ltd. 2Q Consolidated Op Pft KRW4.676T Vs Op KRW10.444T

30 juil. 2025, 23:38 UTC

Résultats

Samsung Electronics Co. Ltd. 2Q Consolidated Rev KRW74.566T Vs KRW74.068T

30 juil. 2025, 23:38 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

30 juil. 2025, 23:28 UTC

Résultats

Budweiser Brewing: Sales Volumes Fell Due to Weakness in China Market >1876.HK

30 juil. 2025, 23:28 UTC

Résultats

Budweiser Brewing 1H Net $409.0M Vs. Net $541.0M >1876.HK

30 juil. 2025, 23:27 UTC

Résultats

Budweiser Brewing 1H Rev $3.14B Vs. $3.40B >1876.HK

30 juil. 2025, 23:24 UTC

Résultats

Grab Holdings 2Q Adj Free Cash Flow $112.0M Vs. $40.0M Year Ago >GRAB

30 juil. 2025, 23:23 UTC

Résultats

Grab Holdings Sees FY25 Adj Ebitda $460M-$480M; Unchanged From 1Q Projection >GRAB

30 juil. 2025, 23:21 UTC

Résultats

Grab Holdings 2Q Adj EBITDA $109M Vs. $64M >GRAB

30 juil. 2025, 23:21 UTC

Résultats

Grab Holdings 2Q Net $20.0M Vs. Loss $68.0M >GRAB

30 juil. 2025, 23:19 UTC

Résultats

Grab Holdings 2Q Rev $819.0M Vs. $664.0M >GRAB

30 juil. 2025, 23:18 UTC

Résultats

Table: Samsung Electro-Mechanics 2Q Consolidated Net KRW137.24B Vs KRW181.38B

30 juil. 2025, 23:18 UTC

Résultats

Samsung Electro-Mechanics Co. Ltd. 2Q Consolidated Net KRW137.24B Vs KRW181.38B

30 juil. 2025, 23:18 UTC

Résultats

Samsung Electro-Mechanics Co. Ltd. 2Q Consolidated Op Pft KRW213.01B Vs Op KRW211.45B

30 juil. 2025, 23:18 UTC

Résultats

Samsung Electro-Mechanics Co. Ltd. 2Q Consolidated Rev KRW2.785T Vs KRW2.573T

30 juil. 2025, 23:16 UTC

Résultats

Microsoft's Cloud Unit Bolsters Earnings -- 3rd Update

30 juil. 2025, 23:10 UTC

Market Talk

Liontown Resources Bear Retains Cash Flow Concerns -- Market Talk

30 juil. 2025, 23:07 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 juil. 2025, 23:07 UTC

Market Talk

Meta Sees Instagram, Facebook Users Spending More Time Watching Videos -- Market Talk

30 juil. 2025, 23:05 UTC

Résultats

Meta Shares Soar as Ad Business Continues to Fuel AI Ambitions -- 2nd Update

30 juil. 2025, 22:55 UTC

Market Talk

Meta Sees Higher Advertising Demand Amid AI Improvements -- Market Talk

30 juil. 2025, 22:39 UTC

Résultats

Microsoft Stock Surges 7% After Earnings. Here Are the Numbers That Blew Investors Away. -- Barrons.com

30 juil. 2025, 22:30 UTC

Acquisitions, Fusions, Rachats

Figma Prices IPO at $33 a Share, Valuing It at $19.3 Billion. The Stock Starts Trading Tomorrow. -- Barrons.com

Comparaison

Variation de prix

Smith & Nephew PLC ADR prévision

Objectif de Prix

By TipRanks

-7.41% baisse

Prévisions sur 12 Mois

Moyen 29.26 USD  -7.41%

Haut 29.26 USD

Bas 29.26 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

1 ratings

0

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

26.64 / 28.37Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.